<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "https://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" dtd-version="1.2" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">IJMABHR</journal-id>
<journal-title-group><journal-title>International Journal of Medical and All Body Health Research</journal-title><abbrev-journal-title>IJMABHR</abbrev-journal-title></journal-title-group>
<issn pub-type="epub">2582-8940</issn>
<publisher><publisher-name>Anfo Publication House</publisher-name></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">282</article-id>
<article-id pub-id-type="doi">10.54660/IJMBHR.2025.6.1.29-37</article-id>
<title-group><article-title>Pathogenesis and Therapeutic Targets of Cytokine Storms in Bacterial Infections</article-title></title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Merie</surname><given-names>Ghufran Mohammed Sadee</given-names></name><xref ref-type="aff" rid="aff1"/></contrib>
<contrib contrib-type="author"><name><surname>Al-hashimi</surname><given-names>Hadeel Tahseen</given-names></name><xref ref-type="aff" rid="aff2"/></contrib>
<contrib contrib-type="author" corresp="yes"><name><surname>Saadi</surname><given-names>Ali M</given-names></name></contrib>
<aff id="aff1"><label>1</label>Department of Medical Laboratory Technologies, Mosul Medical Technical Institute, Northern Technical University, Iraq</aff>
<aff id="aff2"><label>2</label>Department of Medicinal Plant Technologies, Technical Agricultural College, Northern Technical University, Iraq</aff>
</contrib-group>
<pub-date publication-format="electronic" date-type="pub"><year>2025</year></pub-date>
<volume>6</volume>
<issue>1</issue>
<fpage>29</fpage>
<lpage>37</lpage>
<history>
<date date-type="received"><day>11</day><month>11</month><year>2024</year></date>
<date date-type="accepted"><day>15</day><month>12</month><year>2024</year></date>
</history>
<permissions><license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-sa/4.0/?utm"><license-p>CC BY-NC-SA 4.0</license-p></license></permissions>
<self-uri xlink:href="https://www.allmedicaljournal.com/article/282/pathogenesis-and-therapeutic-targets-of-cytokine-storms-in-bacterial-infections"/>
<self-uri content-type="pdf" xlink:href="https://www.allmedicaljournal.com/article/282/download"/>
<abstract><p>It is possible that the abstract of the paper &quot;Pathogenesis and Therapeutic Targets of Cytokine Storms in Bacterial Infections&quot; encapsulates the main conclusions and revelations about the function of cytokine storms in relation to bacterial infections. It could go over the processes that cause cytokine storms, how they affect the host&apos;s immune system, and possible treatment targets that could lessen the negative consequences of these storms. A succinct description of cytokine storms and their significance in bacterial infections. A succinct description of cytokine storms and their significance in bacterial infections. Talk about possible tactics and remedies for controlling or averting cytokine storms. a synopsis of how these findings may affect clinical practice and future study.</p></abstract>
<kwd-group kwd-group-type="author"><kwd>Cytokine Storms</kwd><kwd>Therapeutic Targets</kwd><kwd>Acute Respiratory Distress Syndrome (ARDS)</kwd><kwd>Pro-inflammatory Cytokines</kwd></kwd-group>
</article-meta>
</front>
<back><ref-list><title>References</title>
<ref id="R1"><label>1</label><mixed-citation>Tang XD, Ji TT, Dong JR, Feng H, Chen FQ, Chen X, et al. Pathogenesis and treatment of cytokine storm induced by infectious diseases. International Journal of Molecular Sciences. 2021;22(23):13009. Available from: ncbi.nlm.nih.gov.</mixed-citation></ref>
<ref id="R2"><label>2</label><mixed-citation>Rabaan AA, Al-Ahmed SH, Muhammad J, Khan A, Sule AA, Tirupathi R, et al. Role of inflammatory cytokines in COVID-19 patients: A review on molecular International Journal of Medical and All Body Health Research www.allmedicaljournal.com mechanisms, immune functions, immunopathology, and immunomodulatory drugs to counter cytokine storm. Vaccines. 2021;9(5):436. Available from: mdpi.com.</mixed-citation></ref>
<ref id="R3"><label>3</label><mixed-citation>Marcuzzi A, Melloni E, Zauli G, Romani A, Secchiero P, Maximova N, et al. Autoinflammatory diseases and cytokine storms—imbalances of innate and adaptative immunity. International Journal of Molecular Sciences. 2021;22(20):11241. Available from: mdpi.com.</mixed-citation></ref>
<ref id="R4"><label>4</label><mixed-citation>Tang XD, Ji TT, Dong JR, Feng H, Chen FQ, Chen X, et al. Pathogenesis and treatment of cytokine storm induced by infectious diseases. International Journal of Molecular Sciences. 2021;22(23):13009. Available from: mdpi.com.</mixed-citation></ref>
<ref id="R5"><label>5</label><mixed-citation>Kim JS, Lee JY, Yang JW, Lee KH, Effenberger M, Szpirt W, et al. Immunopathogenesis and treatment of cytokine storm in COVID -19. Theranostics. 2021;11(1):316. Available from: nih.gov.</mixed-citation></ref>
<ref id="R6"><label>6</label><mixed-citation>Ramasamy S, Subbian S. Critical determinants of cytokine storm and type I interferon response in COVID-19 pathogenesis. Clinical Microbiology Reviews. 2021. Available from: asm.org.</mixed-citation></ref>
<ref id="R7"><label>7</label><mixed-citation>Karki R, Kanneganti TD. The &apos;cytokine storm&apos;: molecular mechanisms and therapeutic prospects. Trends in Immunology. 2021. Available from: cell.com.</mixed-citation></ref>
<ref id="R8"><label>8</label><mixed-citation>Reddy H, Kumar Javvaji C, Malali S, Kumar S, Acharya S, Toshniwal S. Navigating the cytokine storm: A comprehensive review of chemokines and cytokines in sepsis. International Journal of Molecular Sciences. 2024. Available from: ncbi.nlm.nih.gov.</mixed-citation></ref>
<ref id="R9"><label>9</label><mixed-citation>Jiang Y, Rubin L, Peng T, Liu L, Xing X, Lazarovici P, et al. Cytokine storm in COVID-19: From viral infection to immune responses, diagnosis, and therapy. International Journal of Biological Sciences. 2022;18(2):459. Available from: nih.gov.</mixed-citation></ref>
<ref id="R10"><label>10</label><mixed-citation>Jarczak D, Nierhaus A. Cytokine storm—definition, causes, and implications. International Journal of Molecular Sciences. 2022. Available from: mdpi.com.</mixed-citation></ref>
<ref id="R11"><label>11</label><mixed-citation>Hu B, Huang S, Yin L. The cytokine storm and COVID‐ 19. Journal of Medical Virology. 2021. Available from: nih.gov.</mixed-citation></ref>
<ref id="R12"><label>12</label><mixed-citation>Valdes-Aguayo JJ, Garza-Veloz I, Badillo-Almaraz JI, Bernal-Silva S, Martinez-Vazquez MC, Juarez-Alcala V, et al. Mitochondria and mitochondrial DNA: Key elements in the pathogenesis and exacerbation of the inflammatory state caused by COVID-19. Medicina. 2021;57(9):928. Available from: mdpi.com.</mixed-citation></ref>
<ref id="R13"><label>13</label><mixed-citation>Rihar E, Peršič V, Jerman A, Plankar Srovin T, Mlakar G, Bezeljak N, et al. Hemoperfusion with CytoSorb® in pediatric patients: A monocentric case series. Journal of Clinical Medicine. 2024;13(21):6587. Available from: mdpi.com.</mixed-citation></ref>
<ref id="R14"><label>14</label><mixed-citation>Müller L, Di Benedetto S. How immunosenescence and inflammaging may contribute to hyperinflammatory syndrome in COVID-19. International Journal of Molecular Sciences. 2021. Available from: mdpi.com.</mixed-citation></ref>
<ref id="R15"><label>15</label><mixed-citation>Pourgholaminejad A, Pahlavanneshan S, Basiri M. COVID‐19 immunopathology with emphasis on Th17 response and cell‐based immunomodulation therapy: Potential targets and challenges. Scandinavian Journal of Immunology. 2022;95(2):e13131. Available from: wiley.com.</mixed-citation></ref>
<ref id="R16"><label>16</label><mixed-citation>Greenfield KG, Badovinac VP, Griffith TS, Knoop KA. Sepsis, cytokine storms, and immunopathology: The divide between neonates and adults. ImmunoHorizons. 2021;5(6):512-522. Available from: aai.org.</mixed-citation></ref>
<ref id="R17"><label>17</label><mixed-citation>Gu Y, Zuo X, Zhang S, Ouyang Z, Jiang S, Wang F, et al. The mechanism behind influenza virus cytokine storm. Viruses. 2021;13(7):1362. Available from: mdpi.com.</mixed-citation></ref>
<ref id="R18"><label>18</label><mixed-citation>Rabaan AA, Al-Ahmed SH, Garout MA, Al-Qaaneh AM, Sule AA, Tirupathi R, et al. Diverse immunological factors influencing pathogenesis in patients with COVID-19: A review on viral dissemination, immunotherapeutic options to counter cytokine storm and inflammatory responses. Pathogens. 2021;10(5):565. Available from: mdpi.com.</mixed-citation></ref>
<ref id="R19"><label>19</label><mixed-citation>Ahmad R, Haque M. Surviving the storm: Cytokine biosignature in SARS-CoV-2 severity prediction. Vaccines. 2022. Available from: mdpi.com.</mixed-citation></ref>
<ref id="R20"><label>20</label><mixed-citation>Yousif SO. Relation of hypercytokinemia (cytokine storm) in viral respiratory SARS-COVID-2. IIARD Journals. Available from: iiardjournals.org.</mixed-citation></ref>
<ref id="R21"><label>21</label><mixed-citation>Bhadoria P, Rathore H. Multi-organ system dysfunction in Covid-19—a review. Journal of Evolution of Medical and Dental Sciences. 2021. Available from: researchgate.net.</mixed-citation></ref>
<ref id="R22"><label>22</label><mixed-citation>Caricchio R, Gallucci M, Dass C, Zhang X, Gallucci S, Fleece D, et al. Preliminary predictive criteria for COVID-19 cytokine storm. Annals of the Rheumatic Diseases. 2021;80(1):88-95. Available from: bmj.com.</mixed-citation></ref>
<ref id="R23"><label>23</label><mixed-citation>Cappanera S, Palumbo M, Kwan SH, Priante G, Martella LA, Saraca LM, et al. When does the cytokine storm begin in COVID-19 patients? A quick score to recognize it. Journal of Clinical Medicine. 2021;10(2):297. Available from: mdpi.com.</mixed-citation></ref>
<ref id="R24"><label>24</label><mixed-citation>van Heerden PV, Abutbul A, Sviri S, Zlotnick E, Nama A, Zimro S, et al. Apoptotic cells for therapeutic use in cytokine storm associated with sepsis—a phase Ib clinical trial. Frontiers in Immunology. 2021;12:718191. Available from: frontiersin.org.</mixed-citation></ref>
<ref id="R25"><label>25</label><mixed-citation>O&apos;Reilly D, McGrath J, Martin-Loeches I. Optimizing artificial intelligence in sepsis management: Opportunities in the present and looking closely to the future. Journal of Intensive Medicine. 2024. Available from: sciencedirect.com.</mixed-citation></ref>
<ref id="R26"><label>26</label><mixed-citation>Hussain S, Mubeen I, Ullah N, Shah SSUD, Khan BA, Zahoor M, et al. Modern diagnostic imaging technique applications and risk factors in the medical field: A review. BioMed Research International. 2022;2022(1):5164970. Available from: wiley.com.</mixed-citation></ref>
<ref id="R27"><label>27</label><mixed-citation>Pascoal E, Wessels JM, Aas‐Eng MK, Abrao MS, Condous G, Jurkovic D, et al. Strengths and limitations of diagnostic tools for endometriosis and relevance in diagnostic test accuracy research. Ultrasound in Obstetrics &amp; Gynecology. 2022;60(3):309-27. Available from: wiley.com.</mixed-citation></ref>
<ref id="R28"><label>28</label><mixed-citation>Liu G, Jiang C, Lin X, Yang Y. Point‐of‐care detection of cytokines in cytokine storm management and beyond: Significance and challenges. View. 2021. Available from: wiley.com.</mixed-citation></ref>
<ref id="R29"><label>29</label><mixed-citation>Mohammed MA. Fighting cytokine storm and immunomodulatory deficiency: By using natural products therapy up to now. Frontiers in Pharmacology. 2023. Available from: frontiersin.org.</mixed-citation></ref>
<ref id="R30"><label>30</label><mixed-citation>Li R, Ye JJ, Gan L, Zhang M, Sun D, Li Y, et al. Traumatic inflammatory response: Pathophysiological role and clinical value of cytokines. European Journal of Trauma and Emergency Surgery. 2024;50(4):1313-30. International Journal of Medical and All Body Health Research www.allmedicaljournal.com Available from: springer.com.</mixed-citation></ref>
<ref id="R31"><label>31</label><mixed-citation>David P, Hansen FJ, Bhat A, Weber GF. An overview of proteomic methods for the study of ‘cytokine storms’. Expert Review of Proteomics. 2021;18(2):83-91. Available from: researchgate.net.</mixed-citation></ref>
<ref id="R32"><label>32</label><mixed-citation>de la Rica R, Borges M, Gonzalez-Freire M. COVID-19: In the eye of the cytokine storm. Frontiers in Immunology. 2020. Available from: ncbi.nlm.nih.gov.</mixed-citation></ref>
<ref id="R33"><label>33</label><mixed-citation>Kaur S, Bansal R, Kollimuttathuillam S, Gowda AM, Singh B, Mehta D, et al. The looming storm: Blood and cytokines in COVID -19. Blood Reviews. 2021;46:100743. Available from: nih.gov.</mixed-citation></ref>
<ref id="R34"><label>34</label><mixed-citation>Stolarski AE, Kim J, Zhang Q, Remick DG. Cytokine drizzle—the rationale for abandoning “cytokine storm”. Shock. 2021. Available from: researchgate.net.</mixed-citation></ref>
<ref id="R35"><label>35</label><mixed-citation>Kang S, Kishimoto T. Interplay between interleukin-6 signaling and the vascular endothelium in cytokine storms. Frontiers in Immunology. 2021. Available from: ncbi.nlm.nih.gov.</mixed-citation></ref>
<ref id="R36"><label>36</label><mixed-citation>Hann Ng W, Chun Hean Tang P, Mahalingam S, Liu X. Repurposing of drugs targeting the cytokine storm induced by SARS‐CoV‐2. Frontiers in Pharmacology. 2023. Available from: ncbi.nlm.nih.gov.</mixed-citation></ref>
<ref id="R37"><label>37</label><mixed-citation>Clark IA. Background to new treatments for COVID‐19, including its chronicity, through altering elements of the cytokine storm. Reviews in Medical Virology. 2021. Available from: wiley.com.</mixed-citation></ref>
<ref id="R38"><label>38</label><mixed-citation>Basheer M, Saad E, Assy N. The cytokine storm in COVID-19: The strongest link to morbidity and mortality in the current epidemic. COVID. 2022. Available from: mdpi.com.</mixed-citation></ref>
<ref id="R39"><label>39</label><mixed-citation>Chan L, Karimi N, Morovati S, Alizadeh K, Kakish JE, Vanderkamp S, et al. The roles of neutrophils in cytokine storms. Viruses. 2021;13(11):2318. Available from: mdpi.com.</mixed-citation></ref>
<ref id="R40"><label>40</label><mixed-citation>Yuan S, Jiang SC, Zhang ZW, Fu YF, Hu J, Li ZL. Quantification of cytokine storms during virus infections. Frontiers in Immunology. 2021;12:659419. Available from: frontiersin.org.</mixed-citation></ref>
<ref id="R41"><label>41</label><mixed-citation>Taya T, Teruyama F, Gojo S. Host-directed therapy for bacterial infections—Modulation of the phagolysosome pathway. Frontiers in Immunology. 2023. Available from: ncbi.nlm.nih.gov.</mixed-citation></ref>
<ref id="R42"><label>42</label><mixed-citation>Wallis RS, O&apos;Garra A, Sher A, Wack A. Host-directed immunotherapy of viral and bacterial infections: Past, present and future. Nature Reviews Immunology. 2023. Available from: nature.com.</mixed-citation></ref>
<ref id="R43"><label>43</label><mixed-citation>McCarty SM, Clasby MC, Sexton JZ. High-Throughput Methods for the Discovery of Small Molecule Modulators of Pancreatic Beta-Cell Function and Regeneration. ASSAY and Drug Development Technologies. 2024;22(3):148-159. Available from: umich.edu.</mixed-citation></ref>
<ref id="R44"><label>44</label><mixed-citation>Ma Q, Tong H, Jing J. High throughput virtual screening strategy to develop a potential treatment for bronchial asthma by targeting interleukin 13 cytokine signaling. Allergologia et Immunopathologia. 2022. Available from: all-imm.com.</mixed-citation></ref>
<ref id="R45"><label>45</label><mixed-citation>Zhang Y, Xu Q, Gao Z, Zhang H, Xie X, Li M. High-throughput screening for optimizing adoptive T cell therapies. Experimental Hematology &amp; Oncology. 2024;13(1):113. Available from: springer.com.</mixed-citation></ref>
<ref id="R46"><label>46</label><mixed-citation>Zhang K, Tang Y, Chen Q, Liu Y. The screening of therapeutic peptides for anti-inflammation through phage display technology. International Journal of Molecular Sciences. 2022;23(15):8554. Available from: mdpi.com.</mixed-citation></ref>
<ref id="R47"><label>47</label><mixed-citation>Chung JY, Thone MN, Kwon YJ. COVID-19 vaccines: The status and perspectives in delivery points of view. Advanced Drug Delivery Reviews. 2021. Available from: nih.gov.</mixed-citation></ref>
<ref id="R48"><label>48</label><mixed-citation>Sharun K, Tiwari R, Yatoo MI, Natesan S, Megawati D, Singh KP, et al. A comprehensive review on pharmacologic agents, immunotherapies, and supportive therapeutics for COVID-19. Narra Journal. 2022;2(3). Available from: nih.gov.</mixed-citation></ref>
<ref id="R49"><label>49</label><mixed-citation>Baker DJ, Arany Z, Baur JA, Epstein JA, June CH. CAR T therapy beyond cancer: The evolution of a living drug. Nature. 2023. Available from: upenn.edu.</mixed-citation></ref>
<ref id="R50"><label>50</label><mixed-citation>Bhol NK, Bhanjadeo MM, Singh AK, Dash UC, Ojha RR, Majhi S, et al. The interplay between cytokines, inflammation, and antioxidants: Mechanistic insights and therapeutic potentials of various antioxidants and anti-cytokine compounds. Biomedicine &amp; Pharmacotherapy. 2024;178:117177. Available from: sciencedirect.com.</mixed-citation></ref>
<ref id="R51"><label>51</label><mixed-citation>Buszko M, Nita-Lazar A, Park JH, Schwartzberg PL, Verthelyi D, Young HA, Rosenberg AS. Lessons learned: New insights on the role of cytokines in COVID-19. Nature Immunology. 2021;22(4):404-411. Available from: nature.com.</mixed-citation></ref>
</ref-list></back>
</article>